Market Drivers of the Spinal Implants Sector
In recent years, there has been a notable increase in the number of spinal implant surgeries conducted globally, driven by advancements in surgical techniques. Innovations in technology have led to the development of a diverse range of interbody devices, which are now frequently utilized as alternatives to traditional bone graft materials in spinal surgeries. Enhanced techniques in spinal implant procedures have also seen the adoption of pedicle screws for posterior instrumentation. Furthermore, the emergence of spinal fusion techniques tailored to various surgical needs, surgeon preferences, and patient conditions has significantly contributed to the rise in spinal implant surgeries. These fusion operations are carried out using interbody fusion with stand-alone cages and can be approached from anterior, lateral, or posterior angles. A study published in February 2023 in the Clinical Orthopaedics and Related Research Journal by the Association of Bone and Joint Surgeons indicates that the demand for posterior spinal fusion procedures is projected to increase by 80% by 2060. This surge in procedures is closely linked to the age-related decline in muscle mass. Consequently, the growing number of spinal implant surgeries is a key factor propelling the growth of the spinal implants market.
Trends in the Spinal Implants Market
The evolution of medical technology has spurred numerous innovations within the spinal sector. One significant advancement is the integration of robotic surgery into spinal procedures, which has garnered considerable attention. Additionally, the use of 3D printing technology is becoming more prevalent in the production of medical devices, leading to the creation of effective spinal implants. Companies have begun to develop and commercialize 3D-printed implants specifically for spinal fusion. For instance, in July 2021, Orthofix Medical introduced its FORZA Ti PLIF Spacer System, a 3D-printed orthopedic device designed for posterior lumbar interbody fusion (PLIF) surgeries. At the launch, the company also reported the first patient implant using this innovative lumbar interbody device. Similarly, in April 2021, Orthofix released the Construx Mini Ti spacer system for anterior cervical discectomy and fusion procedures. In April 2023, ZSFab announced its 3D-printed titanium implant featuring a triply periodic minimal lattice structure, aimed at anterior cervical discectomy and fusion. This device has shown promising results in two clinical cases in the US and received FDA 510(k) clearance in 2021, intended to support the fusion of two vertebrae post disc removal. Numerous companies are preparing to launch their own 3D-printed products, with developments allowing for patient-specific implants that enhance surgical outcomes. In June 2022, Aurora Spine obtained FDA 510(k) clearance for its Dexasolo-L spinal fusion system, which is tailored to the patient's bone density and quality. This system is the first of its kind for the lumbar spine and is expected to be launched soon. Personalized 3D-printed implants are anticipated to facilitate minimally invasive approaches for complex deformities while minimizing patient risks and promoting favorable outcomes. The benefits of 3D printing technology include enhanced safety and efficiency in spinal surgeries, enabling surgeons to pre-plan procedures based on preoperative imaging. Additionally, 3D-printed implants can alleviate stress at the screw-bone interface, thereby reducing the likelihood of implant failure and non-union. As a result, 3D printing technology is poised for a promising future as these implants become more widely utilized.
Spinal Implants Market: Segmental Overview
The spinal implants market is categorized by product into fusion spinal implants and non-fusion spinal implants. The fusion spinal implants segment dominated the market in 2023 and is expected to exhibit the highest CAGR throughout the forecast period.
By procedure, the market is divided into foraminotomy, laminectomy, spinal disc replacement, spine fusion, and discectomy. The laminectomy segment held the largest market share in 2023, while spine fusion is projected to achieve the highest CAGR during the forecast period.
In terms of material, the spinal implants market is segmented into titanium, carbon fiber, and stainless steel. The stainless steel segment led the market in 2023 and is anticipated to register the highest CAGR in the coming years.
Regarding end users, the market is classified into hospitals, diagnostic and imaging centers, and others. The hospitals segment accounted for the largest share of the spinal implants market in 2023 and is expected to maintain the highest CAGR during the forecast period.
Spinal Implants Market: Geographical Overview
The Asia Pacific region is projected to experience the highest CAGR from 2023 to 2031. Countries such as India and China present significant opportunities for the growth of the spinal implants market. In 2023, North America held the largest market share, driven by the increasing adoption of advanced medical device technologies, a high incidence of spinal injuries, and ongoing product innovations by leading companies. For example, the Cleveland Clinic reports approximately 18,000 new traumatic spinal cord injury cases annually in the United States, equating to about 54 cases per million people. Additionally, age-related degeneration contributes to the prevalence of lower back pain (LBP) among the elderly in the US, further driving the demand for spinal surgeries and implantable devices. According to the National Health Service, the lifetime incidence of LBP in the US is estimated at 60-90%, with an annual incidence of 5%. Furthermore, 14.3% of new patients consult physicians each year due to LBP, with around 13 million individuals seeking medical attention for chronic LBP. Thus, the high rates of spinal cord injuries and LBP are favorable for the advancement of the spinal implants market.
Sources
Key primary and secondary sources utilized in the preparation of the spinal implants market report include the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization).